Search research articles
Contact Us
Filters
Showing results (201-210 of 220) with videos related to
Page
of 22
Sort By:
Journal of Medical Genetics
|
December 10, 2002
Clinical and genetic studies of Birt-Hogg-Dubé syndrome
S K Khoo, S Giraud, K Kahnoski, et al.
The British Journal of Dermatology
|
September 26, 2015
Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013
E Sbidian, C Hotz, J Seneschal, et al.
Annales De Dermatologie Et De Venereologie
|
June 8, 2001
[Neurofibromatosis 1: recommendations for management]
S Pinson, A Créange, S Barbarot, et al.
The Pharmacogenomics Journal
|
December 11, 2013
HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis
E Genin, D-P Chen, S-I Hung, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
February 28, 2002
[Neurofibromatosis 1: recommendations for management]
S Pinson, A Créange, S Barbarot, et al.
The British Journal of Dermatology
|
June 30, 2018
A large epidemiological study of erythema multiforme in France, with emphasis on treatment choices
E Kechichian, S Ingen-Housz-Oro, E Sbidian, et al.
The British Journal of Dermatology
|
December 21, 2016
Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults
J Gottlieb, S Ingen-Housz-Oro, M Alexandre, et al.
Journal Francais D'Ophtalmologie
|
May 16, 2002
[Recommendations for the treatment of neurofibromatosis type 1]
S Pinson, A Créange, S Barbarot, et al.
The British Journal of Dermatology
|
July 7, 2020
Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing
L Le Cleach, L Dousset, H Assier, et al.
International Journal of Cancer
|
June 22, 2000
Delays in diagnosis and melanoma prognosis (I): the role of patients
M A Richard, J J Grob, M F Avril, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 220) with videos related to
Sort By:
Page
of 22
Journal of Medical Genetics
|
December 10, 2002
Clinical and genetic studies of Birt-Hogg-Dubé syndrome
S K Khoo, S Giraud, K Kahnoski, et al.
The British Journal of Dermatology
|
September 26, 2015
Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013
E Sbidian, C Hotz, J Seneschal, et al.
Annales De Dermatologie Et De Venereologie
|
June 8, 2001
[Neurofibromatosis 1: recommendations for management]
S Pinson, A Créange, S Barbarot, et al.
The Pharmacogenomics Journal
|
December 11, 2013
HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis
E Genin, D-P Chen, S-I Hung, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
February 28, 2002
[Neurofibromatosis 1: recommendations for management]
S Pinson, A Créange, S Barbarot, et al.
The British Journal of Dermatology
|
June 30, 2018
A large epidemiological study of erythema multiforme in France, with emphasis on treatment choices
E Kechichian, S Ingen-Housz-Oro, E Sbidian, et al.
The British Journal of Dermatology
|
December 21, 2016
Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults
J Gottlieb, S Ingen-Housz-Oro, M Alexandre, et al.
Journal Francais D'Ophtalmologie
|
May 16, 2002
[Recommendations for the treatment of neurofibromatosis type 1]
S Pinson, A Créange, S Barbarot, et al.
The British Journal of Dermatology
|
July 7, 2020
Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing
L Le Cleach, L Dousset, H Assier, et al.
International Journal of Cancer
|
June 22, 2000
Delays in diagnosis and melanoma prognosis (I): the role of patients
M A Richard, J J Grob, M F Avril, et al.
Page
of 22